Depression in Old Age - Diagnostics, Pathophysiology and therapeutic Strategies

被引:5
|
作者
Dafsari, Forugh S. [1 ]
Jessen, Frank [1 ,2 ,3 ]
机构
[1] Univ Klin Koln, Klin Psychiat & Psychotherapie, Cologne, Germany
[2] Univ Klin Koln, Psychiat & Psychotherapie, Cologne, Germany
[3] DZNE, Bonn, Germany
关键词
LATE-LIFE DEPRESSION; MAJOR DEPRESSION; ELECTROCONVULSIVE-THERAPY; HIPPOCAMPAL VOLUME; MENTAL-DISORDERS; RECEPTOR-BINDING; ELDERLY-PATIENTS; META-REGRESSION; RISK-FACTORS; METAANALYSIS;
D O I
10.1055/s-0043-119799
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Late-life depression is a frequent and severe mental disorder. It is characterized by alterations in mood as well as cognitive deficits and somatic symptoms. LLD is associated with various adverse outcomes, such as reduced quality of life, negative impact on physical comorbidities, functional impairments, increased suicide and non-suicide mortality. Moreover, LLD serves as a risk factor for developing all-cause dementia, including Alzheimeros disease. It leads to a frequent use of health care services and remains a serious public health concern. Unfortunately, LLD is often misinterpreted as a physiological aging process and thus remains underdiagnosed and undertreated for years. With a view towards the demographic change LLD is one of the major diagnostic and therapeutic challenges of the aging society. Nevertheless, psychotherapy, pharmacological interventions as well as ECT are effective treatment options. The goal of any treatment for LLD is to ensure full remission, functional recovery and social reintegration. © Georg Thieme Verlag Stuttgart - New York.
引用
下载
收藏
页码:242 / 253
页数:12
相关论文
共 50 条
  • [41] DIAGNOSTICS AND CORRECTION OF DEPRESSION IN SENIOR SCHOOL AGE
    Melnichuk, I. V.
    Kravchenko, N. M.
    SCIENCE AND EDUCATION, 2013, (07): : 183 - +
  • [42] Migraine with aura from pathophysiology to treatment: therapeutic strategies
    G. D’Andrea
    G. Allais
    L. Grazzi
    L. Fumagalli
    Neurological Sciences, 2005, 26 : s104 - s107
  • [43] Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
    Simon Faissner
    Jason R. Plemel
    Ralf Gold
    V. Wee Yong
    Nature Reviews Drug Discovery, 2019, 18 : 905 - 922
  • [44] ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
    Ana-Caroline Raulin
    Sydney V. Doss
    Zachary A. Trottier
    Tadafumi C. Ikezu
    Guojun Bu
    Chia-Chen Liu
    Molecular Neurodegeneration, 17
  • [45] Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies
    Crawley, James T. B.
    Scully, Marie A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 292 - 299
  • [46] Therapeutic strategies in Wilson disease: pathophysiology and mode of action
    Stremmel, Wolfgang
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [47] Hyponatremia in Heart Failure: Revisiting Pathophysiology and Therapeutic Strategies
    Kazory, Amir
    CLINICAL CARDIOLOGY, 2010, 33 (06) : 322 - 329
  • [48] Thrombotic microangiopathy: Differential diagnosis, pathophysiology and therapeutic strategies
    Mayer, SA
    Aledort, LM
    MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (03): : 166 - 175
  • [49] Pathophysiology of arterial vascular disease and novel therapeutic strategies
    Deuse, T.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2015, 29 (05): : 335 - 341
  • [50] "No-reflow": update on diagnosis, pathophysiology and therapeutic strategies
    Montone, Rocco A.
    Camilli, Massimiliano
    Del Buono, Marco Giuseppe
    Meucci, Maria Chiara
    Gurgoglione, Filippo
    Russo, Michele
    Crea, Filippo
    Niccoli, Giampaolo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (06) : 4S - 14S